These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29107051)

  • 1. Added value of
    Ceccaldi M; Jonveaux T; Verger A; Krolak-Salmon P; Houzard C; Godefroy O; Shields T; Perrotin A; Gismondi R; Bullich S; Jovalekic A; Raffa N; Pasquier F; Semah F; Dubois B; Habert MO; Wallon D; Chastan M; Payoux P; ; Stephens A; Guedj E
    Alzheimers Dement; 2018 Mar; 14(3):293-305. PubMed ID: 29107051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Amyloid positron-emission-tomography with [
    Schönecker S; Prix C; Raiser T; Ackl N; Wlasich E; Stenglein-Krapf G; Mille E; Brendel M; Sabri O; Patt M; Barthel H; Bartenstein P; Levin J; Rominger A; Danek A
    Nervenarzt; 2017 Feb; 88(2):156-161. PubMed ID: 27913818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic impact of [
    Zwan MD; Bouwman FH; Konijnenberg E; van der Flier WM; Lammertsma AA; Verhey FR; Aalten P; van Berckel BN; Scheltens P
    Alzheimers Res Ther; 2017 Jan; 9(1):2. PubMed ID: 28093088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Incremental Diagnostic Value of [18F]Florbetaben PET and the Pivotal Role of the Neuropsychological Assessment in Clinical Practice.
    Spallazzi M; Barocco F; Michelini G; Morelli N; Scarlattei M; Baldari G; Ruffini L; Caffarra P
    J Alzheimers Dis; 2019; 67(4):1235-1244. PubMed ID: 30689568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Amyloid Positron Emission Tomography With Changes in Diagnosis and Patient Treatment in an Unselected Memory Clinic Cohort: The ABIDE Project.
    de Wilde A; van der Flier WM; Pelkmans W; Bouwman F; Verwer J; Groot C; van Buchem MM; Zwan M; Ossenkoppele R; Yaqub M; Kunneman M; Smets EMA; Barkhof F; Lammertsma AA; Stephens A; van Lier E; Biessels GJ; van Berckel BN; Scheltens P
    JAMA Neurol; 2018 Sep; 75(9):1062-1070. PubMed ID: 29889941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of Dual-Point Amyloid PET Scans in Appropriate Use Criteria: A Multicenter Study.
    Segovia F; Gómez-Río M; Sánchez-Vañó R; Górriz JM; Ramírez J; Triviño-Ibáñez E; Carnero-Pardo C; Martínez-Lozano MD; Sopena-Novales P
    J Alzheimers Dis; 2018; 65(3):765-779. PubMed ID: 30103321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of early-phase [
    Daerr S; Brendel M; Zach C; Mille E; Schilling D; Zacherl MJ; Bürger K; Danek A; Pogarell O; Schildan A; Patt M; Barthel H; Sabri O; Bartenstein P; Rominger A
    Neuroimage Clin; 2017; 14():77-86. PubMed ID: 28138429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of molecular imaging on the diagnostic process in a memory clinic.
    Ossenkoppele R; Prins ND; Pijnenburg YA; Lemstra AW; van der Flier WM; Adriaanse SF; Windhorst AD; Handels RL; Wolfs CA; Aalten P; Verhey FR; Verbeek MM; van Buchem MA; Hoekstra OS; Lammertsma AA; Scheltens P; van Berckel BN
    Alzheimers Dement; 2013 Jul; 9(4):414-21. PubMed ID: 23164552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of partial volume effect correction on cerebral β-amyloid imaging in APP-Swe mice using [(18)F]-florbetaben PET.
    Brendel M; Delker A; Rötzer C; Böning G; Carlsen J; Cyran C; Mille E; Gildehaus FJ; Cumming P; Baumann K; Steiner H; Haass C; Herms J; Bartenstein P; Rominger A
    Neuroimage; 2014 Jan; 84():843-53. PubMed ID: 24055703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathology and Florbetaben PET in Patients Incorrectly Diagnosed with Alzheimer's Disease.
    Sabbagh MN; Schäuble B; Anand K; Richards D; Murayama S; Akatsu H; Takao M; Rowe CC; Masters CL; Barthel H; Gertz HJ; Peters O; Rasgon N; Jovalekic A; Sabri O; Schulz-Schaeffer WJ; Seibyl J
    J Alzheimers Dis; 2017; 56(2):441-446. PubMed ID: 27983552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Free and Cued Selective Reminding Test in Predicting [18F]Florbetaben PET Results in Mild Cognitive Impairment and Mild Dementia.
    Spallazzi M; Michelini G; Barocco F; Dieci F; Copelli S; Messa G; Scarlattei M; Pavesi G; Ruffini L; Caffarra P
    J Alzheimers Dis; 2020; 73(4):1647-1659. PubMed ID: 31958094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial-Volume Effect Correction Improves Quantitative Analysis of 18F-Florbetaben β-Amyloid PET Scans.
    Rullmann M; Dukart J; Hoffmann KT; Luthardt J; Tiepolt S; Patt M; Gertz HJ; Schroeter ML; Seibyl J; Schulz-Schaeffer WJ; Sabri O; Barthel H
    J Nucl Med; 2016 Feb; 57(2):198-203. PubMed ID: 26541776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additive value of amyloid-PET in routine cases of clinical dementia work-up after FDG-PET.
    Brendel M; Schnabel J; Schönecker S; Wagner L; Brendel E; Meyer-Wilmes J; Unterrainer M; Schildan A; Patt M; Prix C; Ackl N; Catak C; Pogarell O; Levin J; Danek A; Buerger K; Bartenstein P; Barthel H; Sabri O; Rominger A
    Eur J Nucl Med Mol Imaging; 2017 Dec; 44(13):2239-2248. PubMed ID: 28932894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [(18)F]Florbetaben: a review in β-amyloid PET imaging in cognitive impairment.
    Syed YY; Deeks E
    CNS Drugs; 2015 Jul; 29(7):605-13. PubMed ID: 26175116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Utility of Amyloid PET Imaging in the Differential Diagnosis of Atypical Dementias and Its Impact on Caregivers.
    Bensaïdane MR; Beauregard JM; Poulin S; Buteau FA; Guimond J; Bergeron D; Verret L; Fortin MP; Houde M; Bouchard RW; Soucy JP; Laforce R
    J Alzheimers Dis; 2016 Apr; 52(4):1251-62. PubMed ID: 27104896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early-Phase 18F-Florbetaben PET as an Alternative Modality for 18F-FDG PET.
    Son SH; Kang K; Ko PW; Lee HW; Lee SW; Ahn BC; Lee J; Yoon U; Jeong SY
    Clin Nucl Med; 2020 Jan; 45(1):e8-e14. PubMed ID: 31524679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of beta-amyloid-specific florbetaben PET imaging on confidence in early diagnosis of Alzheimer's disease.
    Schipke CG; Peters O; Heuser I; Grimmer T; Sabbagh MN; Sabri O; Hock C; Kunz M; Kuhlmann J; Reininger C; Blankenburg M
    Dement Geriatr Cogn Disord; 2012; 33(6):416-22. PubMed ID: 22814208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal assessment of cerebral β-amyloid deposition in mice overexpressing Swedish mutant β-amyloid precursor protein using 18F-florbetaben PET.
    Rominger A; Brendel M; Burgold S; Keppler K; Baumann K; Xiong G; Mille E; Gildehaus FJ; Carlsen J; Schlichtiger J; Niedermoser S; Wängler B; Cumming P; Steiner H; Herms J; Haass C; Bartenstein P
    J Nucl Med; 2013 Jul; 54(7):1127-34. PubMed ID: 23729696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of
    Doré V; Bullich S; Rowe CC; Bourgeat P; Konate S; Sabri O; Stephens AW; Barthel H; Fripp J; Masters CL; Dinkelborg L; Salvado O; Villemagne VL; De Santi S
    Alzheimers Dement; 2019 Jun; 15(6):807-816. PubMed ID: 31101517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Florbetaben to trace amyloid-β in the Alzheimer brain by means of PET.
    Barthel H; Sabri O
    J Alzheimers Dis; 2011; 26 Suppl 3():117-21. PubMed ID: 21971456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.